BIOMARIN PHARMACEUTICAL INC Inventory
BIOMARIN PHARMACEUTICAL INC (BMRN) had Inventory of $1.78 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-08-06
- 2026-06-30: Inventory, Net $1.78B.
- 2026-03-31: Inventory, Net $1.27B.
- 2025-12-31: Inventory, Net $1.30B.
- 2025-09-30: Inventory, Net $1.38B.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $1.78B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.27B 10-Q · filed 2026-05-05 |
| 2025-12-31 | $1.30B 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.38B 10-Q · filed 2025-10-28 |
| 2025-06-30 | $1.34B 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.27B 10-Q · filed 2025-05-02 |
| 2024-12-31 | $1.23B 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.18B 10-Q · filed 2024-10-31 |
| 2024-06-30 | $1.18B 10-Q · filed 2024-08-05 |
| 2024-03-31 | $1.14B 10-Q · filed 2024-04-26 |
| 2023-12-31 | $1.11B 10-K · filed 2025-02-24 |
| 2023-09-30 | $1.03B 10-Q · filed 2023-11-02 |
| 2023-06-30 | $975.55M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $918.92M 10-Q · filed 2023-04-28 |
| 2022-12-31 | $894.08M 10-K · filed 2024-02-26 |
| 2022-09-30 | $839.46M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $802.32M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $786.36M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $776.67M 10-K · filed 2023-02-27 |
| 2021-09-30 | $749.41M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $710.98M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $713.93M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $698.55M 10-K · filed 2022-02-25 |
| 2020-09-30 | $700.85M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $743.85M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $705.65M 10-Q · filed 2020-05-01 |
| 2019-12-31 | $680.27M 10-K · filed 2021-02-26 |
| 2019-09-30 | $609.05M 10-Q/A · filed 2019-11-04 |
| 2019-06-30 | $578.74M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $534.70M 10-Q · filed 2019-04-29 |
| 2018-12-31 | $530.87M 10-K · filed 2020-02-27 |
| 2018-09-30 | $508.48M 10-Q · filed 2018-10-26 |
| 2018-06-30 | $473.36M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $468.16M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $475.77M 10-K · filed 2019-02-28 |
| 2017-09-30 | $457.39M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $429.83M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $384.14M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $355.13M 10-K · filed 2018-02-26 |
| 2016-09-30 | $347.42M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $326.56M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $296.98M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $271.68M 10-K · filed 2017-02-27 |
| 2015-09-30 | $262.10M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $237.53M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $222.83M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $199.45M 10-K · filed 2016-02-29 |
| 2014-09-30 | $204.44M 10-Q · filed 2014-10-28 |
| 2014-06-30 | $193.50M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $176.89M 10-Q · filed 2014-05-02 |
| 2013-12-31 | $162.60M 10-K · filed 2015-03-02 |
| 2013-09-30 | $148.68M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $142.30M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $135.82M 10-Q · filed 2013-04-29 |
| 2012-12-31 | $128.69M 10-K · filed 2014-02-26 |
| 2012-09-30 | $120.83M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $120.13M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $124.06M 10-Q · filed 2012-04-30 |
| 2011-12-31 | $130.12M 10-K · filed 2013-02-26 |
| 2011-09-30 | $115.63M 10-Q · filed 2011-10-31 |
| 2011-06-30 | $112.30M 10-Q · filed 2011-08-01 |
| 2011-03-31 | $110.07M 10-Q · filed 2011-04-29 |
| 2010-12-31 | $109.70M 10-K · filed 2012-02-22 |
| 2010-09-30 | $91.74M 10-Q · filed 2010-10-29 |
| 2010-06-30 | $83.78M 10-Q · filed 2010-08-04 |
| 2009-12-31 | $78.66M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |